CAPRI HOLDINGS LTD Key Metrics

2 years of history · ending 2025-03-29 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-10
Book Value Per Share
$3
Free Cash Flow Per Share
$1
Cash Per Share
$1
Revenue Per Share
$38
OCF Per Share
$2
Return on Equity
-120.1%
Return on Assets
-19.9%
Return on Invested Capital
-22.9%
Debt to Equity
4.05
Current Ratio
1.14
Quick Ratio
0.61
Asset Turnover
0.75
Days Payables Outstanding
85.60
Days Inventory On Hand
158.33
SBC / Revenue
1.3%
Capex / Revenue
2.9%
Working Capital
$185M
Net Current Asset Value
$-3.32B
Invested Capital
$1.86B
OCF / Net Income
-0.24
FCF / Net Income
-0.13
Accruals Ratio (Sloan)
-28.1%
Net Debt
$1.41B
Net Debt / EBITDA
-2.52
Interest Coverage
-20.32
Cash Coverage
7.59
Capex Coverage
2.20
Tangible Common Equity
$-413M
TCE / Total Assets
-7.9%
Goodwill / Total Assets
3.8%
NOPAT
$-594M
Cash ROIC
5.9%
WC / Revenue
4.2%
Capex / D&A
0.66
Reinvestment Rate
7.4%
Total Payout Ratio
-0.3%
Asset Growth vs Revenue Growth
-8.0%
Revenue 5Y CAGR
-4.4%
EPS 5Y CAGR
FCF 5Y CAGR
-24.8%
EBITDA 5Y CAGR
Book Value 5Y CAGR
-29.9%
Stock Price (FY-end)
$20
Market Cap
$2.40B
P/E Ratio
P/S Ratio
0.54
P/B Ratio
6.52
P/TB Ratio
P/OCF Ratio
8.54
P/FCF Ratio
15.69
Enterprise Value
$3.81B
EV / EBITDA
EV / Sales
0.86
EV / FCF
24.89
FCF Yield
6.4%
Shareholder Yield
-2.3%
Buyback Yield
0.2%
Capex Yield
5.3%
Operating Leverage
Graham Number
Shares Variation (YoY)
1.1%
Beta (5Y)
1.52
Cost of Equity
12.1%
Cost of Debt (after tax)
1.9%
WACC
8.2%
ROIC - WACC Spread
-31.1%
52W High
$45
52W Low
$19
Trailing Return 1Y
-54.6%
Trailing Return 5Y
82.7%
F-Score (Piotroski)
4.00
Z-Score (Altman)
1.87

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates

CAPRI HOLDINGS LTD — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate19.00%19.00%19.00%19.00%25.00%25.00%
State & Local Income Taxes-1.90%2.02%1.30%1.50%-3.90%-2.20%
Foreign Rate Differential1.20%5.22%1.10%-0.20%8.80%2.30%
Other Adjustments1.40%-33.10%-0.70%-1.30%-2.30%-2.60%
Valuation Allowance Change-30.90%9.56%-7.30%-5.80%3.10%-78.80%
Tax Law Change0.00%3.51%2.10%0.00%0.00%
Effective Tax Rate-4.70%25.91%10.10%4.50%19.00%-62.20%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)$10.0M$66.0M$92.0M$29.0M−$54.0M$452.0M
Income Taxes Paid (Cash)

CAPRI HOLDINGS LTD — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Calzaturificio Sicla S.r.l.

Purchase-Price Allocation

Goodwill

$9.0M

CAPRI HOLDINGS LTD — RestructuringNEW

Per-category restructuring disclosures sourced from us-gaap:RestructuringCostAndReserveAxis dimensional XBRL. Negative charges indicate reversals of prior accruals (a sign the original estimate was too aggressive — flattering current-period earnings).

As of 2025-03-29

CategoryClassP&L ChargeCash PaidReserve Balance
Employee SeveranceEmployee Severance+$12M$24M
Facility ClosingFacility Closing+$4M$5M